CN108653320A - The medical usage of ozone carburetion promotion wound, inflammation healing - Google Patents
The medical usage of ozone carburetion promotion wound, inflammation healing Download PDFInfo
- Publication number
- CN108653320A CN108653320A CN201710215185.1A CN201710215185A CN108653320A CN 108653320 A CN108653320 A CN 108653320A CN 201710215185 A CN201710215185 A CN 201710215185A CN 108653320 A CN108653320 A CN 108653320A
- Authority
- CN
- China
- Prior art keywords
- oil
- wound
- ozone
- sore
- injection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
- A61K9/025—Suppositories; Bougies; Bases therefor; Ovules characterised by shape or structure, e.g. hollow layered, coated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to ozone carburetion in minor operation notch or other wounds, mucosal ulcer, diabetes, cervical erosion, anal fissure, anal fistula, soft tissue injury, the tumble injury surface of a wound, recur sexual trauma, running sore, acne, arthritis, degenerative joint, cystitis, dothienesis, nervous disorder osteomyelitis, gangrene, leg breach sore, synovitis, gout, nasosinusitis, spondylitis, scapulohumeral periarthritis, pain in waist and lower extremities, periostitis, application in stomatitis, it is taken orally by described, intraperitoneal injection, bowel lavage, gavage, intravenous injection, it is subcutaneously injected, intramuscular injection, it is applied with, the mode of drops and suppository, which is given, can effectively prevent and treat above-mentioned disease.
Description
Technical field
The invention belongs to pharmaceutical technology fields, and in particular to ozone carburetion is created for the treatment of wound and inflammation and with treatment
The combination therapies of wound and inflammation.
Background technology
Velio Bocci exist《Ozone therapy》Many can be played using the ozone gas of low dosage by being outlined in one book
Beneficial functions, and without side-effects, i.e. ozone therapy（See what Velio Bocci write《Oxygen-Ozone Therapy》, Beijing
University Hospital publishing house, 2004）.Ozone therapy can be realized by a variety of administration routes, and be generated not for various disease
Same effect.The external application of ozone carburetion is as antiseptic, deodorant for treating for skin disease drugs such as bedsore and ulcer.Therefore,
Know that ozone has oxidation and antibacterial action.By the direct gavage of ozone carburetion controlling for the microbial gastritis of H. pylori
It treats.Ozone gas is subcutaneously injected to treat slow virus hepatitis and vascular conditions in muscle.Vagina is passed directly into ozone gas
Inflammation and bacterium infection can be cured.Ozone gas is directly mixed with the blood of certain volume in vitro, then is fed back to patient
It is referred to as self hemotherapy, human internal environment can be improved, reduces the sensibility and enhancing immunity of organisms of body.Rectum is direct
Blowing ozone's gas can improve the symptom of Parkinson's disease（See Lamberto Re, Mohamed N. Mawsouf, Silvia
Menendez, Olga S. Leon, Gregorio M. Sanchez, and Frank Hernandez write《Ozone
Therapy: Clinical and Basic Evidence of Its Therapeutic Potential》, Archives
Of Medical Research, 2008,39: 17-26）.Abdominal cavity to ozone gas can cardioprotection from Acute myocardial obstruct
The damage of plug（Clara Di Filippo, Margherita Luongo, Raffaele Marfella, Franca
Ferraraccio, Biagio Lettieri, Annalisa Capuano, Francesco Rossi, Michele D'
What Amico write《Oxygen/ozone protects the heart from acute myocardial infarction
through local increase of eNOS activity and endothelial progenitor cells
recruitment》, Naunyn-Schmied Arch Pharmacol, 2010,382:287–291）.Structurally, although
Ozone carburetion and ozone gas（:O-O-O）It is not same substance, but ozone carburetion is obtained by the addition ozone to oil,
Therefore there is ozonide structure in the molecule thereof, it is similar to the function of ozone gas.Any of the above administration route shows ozone
Directly it can be absorbed by organisms and function in a manner of gas.The function of ozone gas may by following three approach come
It realizes：（1）, ozone pass through biochemical reaction in vivo, generate the substance of similar active oxygen（Hydroxyl radical free radical OH-, super oxygen it is cloudy
Ion O2 -Deng）, body oxidation-reduction system is affected extensively；（2）, ozone can cause endothelial progenitor cells assemble and promote an oxygen
Change nitrogen（NO）Generation, play the role of vasodilatory；（3）, ozone can inducing bone marrow stem cell to vascular injury site, promote
It is rebuild into damage vascular repair, but specific mechanism is still not clear.
There are many defects for above-mentioned administration route：It is contacted on the way with too many substance, it is difficult to ensure that gas enters having for body
Imitate concentration.If giving the excessive body that easily induces generates uncomfortable reaction, and operating process is cumbersome, along with the course for the treatment of is longer, patient
It is difficult to receive.Especially self hemotherapy, 2~3 times weekly, continuous 10 weeks as a treatment course.The present invention is with oil and ozone addition
Mode obtains ozone carburetion, then this oil is wrapped up with capsulae enterosolubilis, can overcome the shortcomings for directly using ozone gas.
Both ensured that ozone carburetion was not contacted with extraneous any substance, can also preserve steadily in the long term under normal conditions；Control ozone can also be quantified
Carburetion enters body, to avoid passing through other administering mode administrations, artificially causes dose improper.Ozone carburetion capsulae enterosolubilis
Administration route is directly oral, and minimum is injured to body, and operation is simple, is convenient for carrying, and has been established for its popularization good
Basis.
In ozonizing oil product, ozonisation olive oil, sunflower oil, soybean oil are used for ulcer as antiseptic, deodorant
The topical drug of equal treating for skin disease has listed.But by ozone carburetion be made the form of capsulae enterosolubilis pass through it is directly oral
Mode enters body and generates effect, there is no report at present.In the present invention, by directly taking orally ozone carburetion capsulae enterosolubilis,
Intraperitoneal injection, bowel lavage, gavage, intravenous injection, hypodermic injection, intramuscular injection, external application, drops and suppository mode, can generate
Drug effect.
Invention content
The purpose of the present invention is preventing and treating various wounds and inflammation using ozonisation oil formulation and administration route, make
It is standby easy, of low cost.It verifies by clinic application, the present invention has significant in efficacy, has no toxic side effect, the advantages that high efficiency.
In the present invention, why select one kind in the various oil described in claim 1,2, two kinds and two or more,
It is because these oily unsaturated fatty acid contents are higher, the unsaturated fatty acid of wherein walnut oil is up to 92% or more, in unsaturation
At least one olefinic double bond in fatty acid structure.If by claim 1,2 one kind, two kinds and it is two or more contain insatiable hunger
High oil is mixed with one kind in claim 3~7, two kinds and two or more surfactants with aliphatic acid, also can with it is smelly
Addition reaction occurs for oxygen.As long as it can be seen that in the structure of addition product there are alkene unsaturated bond can with ozone occur addition reaction,
Unsaturated bond number is more, and reaction is more easy to happen, and more with the amount of ozone addition, and addition product can carry ozone molecule
Number is also more.
In order to achieve the above objectives, the technical solution adopted by the present invention will combine following production process and embodiment to carry out
Simple illustration.
1, ozone gas is prepared.
2, ozone carburetion is prepared.
3, ozonisation olive oil capsulae enterosolubilis is prepared.
4, the ozone carburetion capsulae enterosolubilis containing surfactant is prepared.
5, the ozone carburetion capsulae enterosolubilis containing cosurfactant and surfactant is prepared.
6, olive oil capsule and ozonisation olive oil are ozonized to minor operation notch or other wounds, mucosal ulcer, glycosuria
Foot disease, cervical erosion, anal fissure, anal fistula, soft tissue injury, the tumble injury surface of a wound, recurrence sexual trauma, running sore, acne, arthritis, joint
Degeneration, cystitis, dothienesis, nervous disorder osteomyelitis, gangrene, leg breach sore, synovitis, gout, nasosinusitis, spondylitis, shoulder
The Experiment on therapy of Zhou Yan, pain in waist and lower extremities, periostitis, stomatitis.
Specific implementation mode
It elaborates with reference to embodiments to the specific implementation mode of the present invention.
Embodiment 1 ozonizes olive oil and prepares
1, ozone gas is prepared.The present invention prepares ozone gas using medical oxygen by ozone generator.
DRO3-A type ozone machines selected from Xi'an Derun Bio-Technology Co., Ltd.'s design production（Gong Shuai≤55W）.
2, it prepares ozone carburetion and ozone carburetion capsulae enterosolubilis whole process need be carried out at 20~25 DEG C, it is ensured that ozonisation
Pyrolytic reaction will not occur for oil.
3, olive oil 3kg is placed in reaction kettle；Ozone is with 150m3/ h flow velocitys are added, and total reaction time is 20 hours.Reaction
After, residual air inactivation.
4, a concentration of 40 mg/L of ozonisation olive oil is obtained, 25 DEG C can stablize preservation ten months.
Embodiment 2 ozonizes olive oil capsulae enterosolubilis and prepares
Prepare ozonisation olive oil capsulae enterosolubilis.
（1）, capsule material preparation:By weight 3：3：1：1 ratio weighs water, gelatin, glycerine and glutinous rice flour or starch falls
Enter in glue tank, temperature is first arranged to 75 DEG C when colloidal sol, starts when temperature reaches 60 DEG C plus water, adds water 10 minutes, uses hand
Touching has micro- boiling hot feeling, is initially added into glycerine, stirs 2 minutes, takes 2 times, refunded in glue tank from glue pot bottom, adds gelatin rapidly,
Mixing time is 2 hours, and temperature is set as 60 DEG C after stirring, stands de-bubbled 8 hours.
（2）, using pressing prepare ozonisation olive oil capsulae enterosolubilis, capacity 0.25mL.
22 DEG C of glue capsules of room temperature, rubber thickness are 0.7mm, and capacity 0.25mL, soft capsule obtained is cooling 8 in rotating cage
Hour, it comes out of steamer, is drying to obtain ozonisation olive oil capsulae enterosolubilis, it is spare that refrigeration is protected from light in 4 DEG C.
It is prepared by the capsulae enterosolubilis that embodiment 3 ozonizes olive oil, soybean oil and peanut oil miscella
1, ozone gas is prepared.The present invention prepares ozone gas using medical oxygen by ozone generator.
DRO3-A type ozone machines selected from Xi'an Derun Bio-Technology Co., Ltd.'s design production（Gong Shuai≤55W）.
2, it prepares ozone carburetion and ozone carburetion capsulae enterosolubilis whole process need be carried out at 20~25 DEG C, it is ensured that ozonisation
Pyrolytic reaction will not occur for oil.
3, in olive oil 1kg, soybean oil 1kg and peanut oil 1kg merging reaction kettles；Ozone is with 150m3/ h flow velocitys are added, always
Reaction time is 20 hours.After reaction, residual air inactivates.
4, it is 40mg/L to obtain ozonisation miscella concentration, and 25 DEG C can stablize preservation ten months.
5, ozonisation miscella capsulae enterosolubilis is prepared.
（1）, capsule material preparation:By weight 3：3：1：1 ratio weighs water, gelatin, glycerine and glutinous rice flour or starch falls
Enter in glue tank, temperature is first arranged to 75 DEG C when colloidal sol, starts when temperature reaches 60 DEG C plus water, adds water 10 minutes, uses hand
Touching has micro- boiling hot feeling, is initially added into glycerine, stirs 2 minutes, takes 2 times, refunded in glue tank from glue pot bottom, adds gelatin rapidly,
Mixing time is 2 hours, and temperature is set as 60 DEG C after stirring, stands de-bubbled 8 hours.
（2）, using pressing prepare ozonisation miscella capsulae enterosolubilis, capacity 0.25mL.
22 DEG C of glue capsules of room temperature, rubber thickness are 0.7mm, and capacity 0.25mL, soft capsule obtained is cooling 8 in rotating cage
Hour, it comes out of steamer, is drying to obtain ozonisation miscella capsulae enterosolubilis, it is spare that refrigeration is protected from light in 4 DEG C.
It is prepared by ozonisation olive oil capsulae enterosolubilis of the embodiment 4 containing surfactant
1, ozone gas is prepared.The present invention prepares ozone gas using medical oxygen by ozone generator.
DRO3-A type ozone machines selected from Xi'an Derun Bio-Technology Co., Ltd.'s design production（Gong Shuai≤55W）.
2, it prepares ozone carburetion and ozone carburetion capsulae enterosolubilis whole process need be carried out at 20~25 DEG C, it is ensured that ozonisation
Pyrolytic reaction will not occur for oil.
3, olive oil 3kg is placed in reaction kettle, is slowly added to sorbitan monooleate polyoxyethylene ether（Tween 80）
20mL, mixing, ozone is with 150m3/ h flow velocitys are added, and total reaction time is 20 hours.After reaction, residual air inactivates.
4, a concentration of 40 mg/L of ozonisation olive oil is obtained, 25 DEG C can stablize preservation ten months.
5, the ozonisation olive oil capsulae enterosolubilis containing surfactant is prepared.
（1）, capsule material preparation:By weight 3：3：1：1 ratio weighs water, gelatin, glycerine and glutinous rice flour or starch falls
Enter in glue tank, temperature is first arranged to 75 DEG C when colloidal sol, starts when temperature reaches 60 DEG C plus water, adds water 10 minutes, uses hand
Touching has micro- boiling hot feeling, is initially added into glycerine, stirs 2 minutes, takes 2 times, refunded in glue tank from glue pot bottom, adds gelatin rapidly,
Mixing time is 2 hours, and temperature is set as 60 DEG C after stirring, stands de-bubbled 8 hours.
（2）, using pressing prepare ozonisation olive oil capsulae enterosolubilis, capacity 0.25mL.
22 DEG C of glue capsules of room temperature, rubber thickness are 0.7mm, and capacity 0.25mL, soft capsule obtained is cooling 8 in rotating cage
Hour, it comes out of steamer, is drying to obtain the ozonisation olive oil capsulae enterosolubilis containing surfactant, it is spare that refrigeration is protected from light in 4 DEG C.
Embodiment 5 is prepared containing the ozonisation olive oil capsulae enterosolubilis of surfactant and cosurfactant
1, ozone gas is prepared.The present invention prepares ozone gas using medical oxygen by ozone generator.
DRO3-A type ozone machines selected from Xi'an Derun Bio-Technology Co., Ltd.'s design production（Gong Shuai≤55W）.
2, it prepares ozone carburetion and ozone carburetion capsulae enterosolubilis whole process need be carried out at 20~25 DEG C, it is ensured that ozonisation
Pyrolytic reaction will not occur for oil.
3, olive oil 3kg is placed in reaction kettle, is slowly added to sorbitan monooleate polyoxyethylene ether（Tween 80）
20mL and straight alcohol 20mL, mixing, ozone is with 150m3/ h flow velocitys are added, and total reaction time is 20 hours.After reaction, remaining
Gas inactivates.
4, a concentration of 40 mg/L of ozonisation olive oil is obtained, 25 DEG C can stablize preservation ten months.
5, the ozonisation olive oil capsulae enterosolubilis containing surfactant and cosurfactant is prepared.
（1）, capsule material preparation:By weight 3：3：1：1 ratio weighs water, gelatin, glycerine and glutinous rice flour or starch falls
Enter in glue tank, temperature is first arranged to 75 DEG C when colloidal sol, starts when temperature reaches 60 DEG C plus water, adds water 10 minutes, uses hand
Touching has micro- boiling hot feeling, is initially added into glycerine, stirs 2 minutes, takes 2 times, refunded in glue tank from glue pot bottom, adds gelatin rapidly,
Mixing time is 2 hours, and temperature is set as 60 DEG C after stirring, stands de-bubbled 8 hours.
（2）, using pressing prepare ozonisation olive oil capsulae enterosolubilis, capacity 0.25mL.
22 DEG C of glue capsules of room temperature, rubber thickness are 0.7mm, and capacity 0.25mL, soft capsule obtained is cooling 8 in rotating cage
Hour, it comes out of steamer, is drying to obtain the ozonisation olive oil capsulae enterosolubilis containing surfactant and cosurfactant, is protected from light in 4 DEG C
It refrigerates spare.
The effect of 6 present invention ozonisation olive oil of embodiment promotes wound, inflammation healing
Specific experiment process is as follows:
The clinical observation on the therapeutic effect of drug of the present invention
1, clinical case：
Selection 2010 ~ 2016 since the demonstration areas Yang Ling hospital diagnosis postoperative or other wounds, inflammatory patients 1040,
Wound inflammatory type includes minor operation notch or other wounds, mucosal ulcer, diabetes, cervical erosion, anal fissure, and anal fistula is soft
Tissue damage, the tumble injury surface of a wound, recurrence sexual trauma, running sore, acne, arthritis, degenerative joint, cystitis, dothienesis, nervous disorder bone
Marrow inflammation, gangrene, leg breach sore, synovitis, gout, nasosinusitis, spondylitis, scapulohumeral periarthritis, pain in waist and lower extremities, periostitis, stomatitis.On
Stating each sick 40 case, patient is randomly divided into two groups for the treatment of group and control group, treatment group 20, control group 20, and in total 26
Kind disease.Age, gender, wound inflammatory type and the rank random distribution of two groups of cases for the treatment of group and control group, no significant difference,
It is comparable, two groups are kept on a diet as required.
2, usage and dosage：
The ozonisation olive oil and its capsule preparations, external application that treatment group patient is prepared using the embodiment of the present invention 1 and 2 embrocate ozone
Change olive oil (dose is selected according to wound length) and uniformly embrocates wound or site of disease, once a day, 3 days as one therapeutic course, for
Wound；Control group injects drug for diminishing inflammation and antibiosis or embrocates or spray or routine clinical treatment drug, 3 days as one therapeutic course；Gout
Patient takes allopurinol.It is used in treatment group：The ozonisation olive oil capsule preparations of the present invention are taken every time, it is early daily to be administered at empty stomach
1 time, 1/d, 90 days as a treatment course, for inflammation.
3, efficacy determination：
(1) it fully recovers：Wound healing, knot is silly and falls off, and wound healing is without scar；Inflammation, pain and swelling, diabrosis are suppurated disappearance；Bone
Matter enhances.
Acute, chronic cystitis efficacy determination：The symptoms such as frequent micturition, urgent urination, odynuria, wing flesh tenderness, pain in back and loin disappear；Row
Urine is normal, body recovery from illness.
Arthritis, degenerative joint, synovitis, gout efficacy determination：Arthroncus, pain disappear, and flexion-extension motion range is extensive
Multiple normal, walking is freely.
Anal fissure efficacy determination：After medication, pain, constipation, bleeding disappear, and follow-up is not recurred for 1 year.
(2) it improves：Diffusate is reduced, and the surface of a wound reduces area>20, depth shallower, no secretion, granulation tissue growth；It is scorching
Disease, pain slightly disappear, sclerotin enhancing；Remission.
(3) invalid：Surface of a wound area and depth are without change.Inflammation, pain symptom do not improve；Symptom is unchanged.
Note：Effectively=recovery from illness+improvement.
4, result：
1 minor operation notch of table or other trauma care groups and control group curative effect compare
| Group | Number of cases | Recovery from illness/example | Improvement/example | In vain/example | Effective percentage/% | Recurrence |
| Treatment group | 20 | 20 | 0 | 0 | 100 | 0 |
| Control group | 20 | 15 | 5 | 0 | 100 | 0 |
2 mucosal ulcer treatment group of table and control group curative effect compare
| Group | Number of cases | Recovery from illness/example | Improvement/example | In vain/example | Effective percentage/% | Recurrence |
| Treatment group | 20 | 20 | 0 | 0 | 100 | 0 |
| Control group | 20 | 10 | 10 | 0 | 100 | 0 |
3 diabetic foot group of table and control group curative effect compare
| Group | Number of cases | Recovery from illness/example | Improvement/example | In vain/example | Effective percentage/% | Recurrence |
| Treatment group | 20 | 20 | 0 | 0 | 100 | 0 |
| Control group | 20 | 7 | 4 | 9 | 55 | 0 |
4 cervical erosion treatment group of table and control group curative effect compare
| Group | Number of cases | Recovery from illness/example | Improvement/example | In vain/example | Effective percentage/% | Recurrence |
| Treatment group | 20 | 20 | 0 | 0 | 100 | 0 |
| Control group | 20 | 5 | 6 | 9 | 55 | 0 |
5 anal fissure treatment group of table and control group curative effect compare
| Group | Number of cases | Recovery from illness/example | Improvement/example | In vain/example | Effective percentage/% | Recurrence |
| Treatment group | 20 | 20 | 0 | 0 | 100 | 0 |
| Control group | 20 | 10 | 3 | 7 | 65 | 0 |
6 Treatment of Anal Fistula group of table and control group curative effect compare
| Group | Number of cases | Recovery from illness/example | Improvement/example | In vain/example | Effective percentage/% | Recurrence |
| Treatment group | 20 | 20 | 0 | 0 | 100 | 0 |
| Control group | 20 | 3 | 7 | 10 | 50 | 0 |
7 soft tissue injury treatment group of table and control group curative effect compare
| Group | Number of cases | Recovery from illness/example | Improvement/example | In vain/example | Effective percentage/% | Recurrence |
| Treatment group | 20 | 20 | 0 | 0 | 100 | 0 |
| Control group | 20 | 11 | 7 | 2 | 90 | 0 |
8 tumble injury Wound treating group of table and control group curative effect compare
| Group | Number of cases | Recovery from illness/example | Improvement/example | In vain/example | Effective percentage/% | Recurrence |
| Treatment group | 20 | 20 | 0 | 0 | 100 | 0 |
| Control group | 20 | 12 | 7 | 1 | 95 | 0 |
9 recurrent trauma care group of table and control group curative effect compare
| Group | Number of cases | Recovery from illness/example | Improvement/example | In vain/example | Effective percentage/% | Recurrence |
| Treatment group | 20 | 20 | 0 | 0 | 100 | 0 |
| Control group | 20 | 13 | 5 | 2 | 90 | 0 |
10 running sore treatment group of table and control group curative effect compare
| Group | Number of cases | Recovery from illness/example | Improvement/example | In vain/example | Effective percentage/% | Recurrence |
| Treatment group | 20 | 20 | 0 | 0 | 100 | 0 |
| Control group | 20 | 5 | 9 | 6 | 70 | 0 |
11 acne treatment group of table and control group curative effect compare
| Group | Number of cases | Recovery from illness/example | Improvement/example | In vain/example | Effective percentage/% | Recurrence |
| Treatment group | 20 | 20 | 0 | 0 | 100 | 0 |
| Control group | 20 | 3 | 5 | 12 | 60 | 0 |
12 arthritis treatment group of table and control group curative effect compare
| Group | Number of cases | Recovery from illness/example | Improvement/example | In vain/example | Effective percentage/% | Recurrence |
| Treatment group | 20 | 15 | 5 | 0 | 100 | 0 |
| Control group | 20 | 2 | 5 | 13 | 35 | 2 |
13 degenerative joint treatment group of table and control group curative effect compare
| Group | Number of cases | Recovery from illness/example | Improvement/example | In vain/example | Effective percentage/% | Recurrence |
| Treatment group | 20 | 15 | 4 | 1 | 95 | 0 |
| Control group | 20 | 1 | 3 | 16 | 20 | 4 |
14 cystitis treatments group of table and control group curative effect compare
| Group | Number of cases | Recovery from illness/example | Improvement/example | In vain/example | Effective percentage/% | Recurrence |
| Treatment group | 20 | 13 | 5 | 2 | 90 | 0 |
| Control group | 20 | 1 | 5 | 14 | 30 | 4 |
15 dothienesis treatment group of table and control group curative effect compare
| Group | Number of cases | Recovery from illness/example | Improvement/example | In vain/example | Effective percentage/% | Recurrence |
| Treatment group | 20 | 20 | 0 | 0 | 100 | 0 |
| Control group | 20 | 5 | 5 | 10 | 50 | 7 |
16 nervous disorder osteomyelitis treatment group of table and control group curative effect compare
| Group | Number of cases | Recovery from illness/example | Improvement/example | In vain/example | Effective percentage/% | Recurrence |
| Treatment group | 20 | 15 | 3 | 2 | 90 | 0 |
| Control group | 20 | 1 | 3 | 16 | 20 | 4 |
The gangrenous treatment group of table 17 and control group curative effect compare
| Group | Number of cases | Recovery from illness/example | Improvement/example | In vain/example | Effective percentage/% | Recurrence |
| Treatment group | 20 | 13 | 5 | 2 | 90 | 0 |
| Control group | 20 | 2 | 5 | 13 | 35 | 2 |
18 leg breach sore treatment group of table and control group curative effect compare
| Group | Number of cases | Recovery from illness/example | Improvement/example | In vain/example | Effective percentage/% | Recurrence |
| Treatment group | 20 | 20 | 0 | 0 | 100 | 0 |
| Control group | 20 | 10 | 5 | 2 | 90 | 0 |
19 synovitis treatment group of table and control group curative effect compare
| Group | Number of cases | Recovery from illness/example | Improvement/example | In vain/example | Effective percentage/% | Recurrence |
| Treatment group | 20 | 18 | 1 | 1 | 95 | 0 |
| Control group | 20 | 1 | 4 | 15 | 25 | 4 |
20 gout treatment group of table and control group curative effect compare
| Group | Number of cases | Recovery from illness/example | Improvement/example | In vain/example | Effective percentage/% | Recurrence |
| Treatment group | 20 | 16 | 2 | 2 | 90 | 0 |
| Control group | 20 | 2 | 10 | 8 | 60 | 5 |
21 Nasosinusitis therapy group of table and control group curative effect compare
| Group | Number of cases | Recovery from illness/example | Improvement/example | In vain/example | Effective percentage/% | Recurrence |
| Treatment group | 20 | 13 | 5 | 2 | 90 | 0 |
| Control group | 20 | 1 | 10 | 9 | 55 | 8 |
22 spondylitis treatment group of table and control group curative effect compare
| Group | Number of cases | Recovery from illness/example | Improvement/example | In vain/example | Effective percentage/% | Recurrence |
| Treatment group | 20 | 14 | 4 | 2 | 90 | 0 |
| Control group | 20 | 2 | 7 | 11 | 45 | 7 |
23 scapulohumeral periarthritis treatment group of table and control group curative effect compare
| Group | Number of cases | Recovery from illness/example | Improvement/example | In vain/example | Effective percentage/% | Recurrence |
| Treatment group | 20 | 15 | 4 | 1 | 95 | 0 |
| Control group | 20 | 1 | 6 | 14 | 35 | 5 |
24 pain in waist and lower extremities treatment group of table and control group curative effect compare
| Group | Number of cases | Recovery from illness/example | Improvement/example | In vain/example | Effective percentage/% | Recurrence |
| Treatment group | 20 | 20 | 0 | 0 | 100 | 0 |
| Control group | 20 | 1 | 2 | 17 | 15 | 0 |
25 periostitis treatment group of table and control group curative effect compare
| Group | Number of cases | Recovery from illness/example | Improvement/example | In vain/example | Effective percentage/% | Recurrence |
| Treatment group | 20 | 20 | 0 | 0 | 100 | 0 |
| Control group | 20 | 3 | 5 | 12 | 40 | 4 |
26 stomatitis treatment group of table and control group curative effect compare
| Group | Number of cases | Recovery from illness/example | Improvement/example | In vain/example | Effective percentage/% | Recurrence |
| Treatment group | 20 | 20 | 0 | 0 | 100 | 0 |
| Control group | 20 | 7 | 8 | 5 | 75 | 0 |
The above results show that treatment group's recovery from illness ratio is noticeably greater than control group, illustrate that ozonizing olive oil cures wound and inflammation
Significant effect, to various wounds, mucosal ulcer, diabetes, cervical erosion, anal fissure, anal fistula, soft tissue injury, the tumble injury surface of a wound,
Recur sexual trauma, running sore, acne, arthritis, degenerative joint, cystitis, dothienesis, nervous disorder osteomyelitis, gangrene, leg breach
Sore, synovitis, gout, nasosinusitis, spondylitis, scapulohumeral periarthritis, pain in waist and lower extremities, periostitis, stomatitis have healing and therapeutic effect.
It is obvious to a person skilled in the art that invention is not limited to the details of the above exemplary embodiments, Er Qie
In the case of without departing substantially from spirit or essential attributes of the invention, the present invention can be realized in other specific forms.Therefore, no matter
From the point of view of which point, the present embodiments are to be considered as illustrative and not restrictive, and the scope of the present invention is by appended power
Profit requires rather than above description limits, it is intended that all by what is fallen within the meaning and scope of the equivalent requirements of the claims
Variation is included within the present invention.
The above described is only a preferred embodiment of the present invention, being not that the invention has other forms of limitations, appoint
What those skilled in the art changed or be modified as possibly also with the technology contents of the disclosure above equivalent variations etc.
Imitate embodiment.But it is every without departing from technical solution of the present invention content, according to the technical essence of the invention to above example into
Row modification or equivalent replacement of some of the technical features.All within the spirits and principles of the present invention, appoint made by
What modification, equivalent replacement, improvement etc., should all be included in the protection scope of the present invention.
Claims (9)
1. a kind of application of ozone carburetion in wound, inflammation healing, which is characterized in that oil is at least selected from olive oil, soya-bean oil, certain herbaceous plants with big flowers
Flower seed oil, linseed oil, rapeseed oil, Semen setariae oil, corn oil, maize germ oil, sesame oil, cottonseed oil, castor oil, peanut oil,
Tea-seed oil, perilla herb oil, safflower seed oil, apricot kernel oil, hazelnut oil, walnut oil, pine-seed oil, shinyleaf yellowhorn oil, edible blend oil, cod-liver oil
With one kind in fish oil, by the electrophilic addition ozone to oil, it is the glutinous of 0.1~0.75mL that capacity, which is made, in obtained ozone carburetion
Rice or starch material capsulae enterosolubilis are contained with 2~100mL vials, with the dosage of 0.1 ~ 100mL, by oral route administration and
It is given by the way of intraperitoneal injection, bowel lavage, gavage, intravenous injection, hypodermic injection, intramuscular injection, external application, drops and suppository,
It can be used in preparing and prevent and treat postoperative or other wounds and inflammation disease drug, it includes small hand that wound inflammatory type, which is selected from,
Art notch or other wounds, mucosal ulcer, diabetes, cervical erosion, anal fissure, anal fistula, soft tissue injury, the tumble injury surface of a wound are multiple
Send out sexual trauma, running sore, acne, arthritis, degenerative joint, cystitis, dothienesis, nervous disorder osteomyelitis, gangrene, leg breach
Any type in sore, synovitis, gout, nasosinusitis, spondylitis, scapulohumeral periarthritis, pain in waist and lower extremities, periostitis, stomatitis.
2. oil according to claim 1, which is characterized in that carry out mixing and two two-by-two to oil described in claim 1
Mixing of the kind to oil, by electrophilic addition ozone, glutinous rice or shallow lake that capacity is 0.1~0.75mL is made in obtained ozone carburetion
Powder material capsulae enterosolubilis is contained with 2~100mL vials, with the dosage of 0.1 ~ 100mL, is administered and uses by oral route abdomen
Chamber injection, bowel lavage, gavage, intravenous injection, hypodermic injection, intramuscular injection, external application, drops and suppository mode give, Neng Gouyong
Postoperative or other wounds and inflammation disease drug is prevented and treated in preparing, it includes minor operation notch that wound inflammatory type, which is selected from,
Or other wounds, mucosal ulcer, diabetes, cervical erosion, anal fissure, anal fistula, soft tissue injury, the tumble injury surface of a wound, recurrent wound
Wound, running sore, acne, arthritis, degenerative joint, cystitis, dothienesis, nervous disorder osteomyelitis, gangrene, leg breach sore, synovial membrane
Any type in inflammation, gout, nasosinusitis, spondylitis, scapulohumeral periarthritis, pain in waist and lower extremities, periostitis, stomatitis.
3. any one oil according to claims 1 to 2, which is characterized in that by selecting nonionic surfactant, the moon
One kind, two kinds and two or more mixing in ionic surface active agent and cationic surfactant, with claim 1~2
Any one of described oil mixes, and by electrophilic addition ozone, obtains the ozone carburetion containing surfactant and capacity is made
It is contained for the glutinous rice or starch material capsulae enterosolubilis of 0.1~0.75mL, with 2~100mL vials, with the agent of 0.1 ~ 100mL
Amount is administered and by oral route using intraperitoneal injection, bowel lavage, gavage, intravenous injection, hypodermic injection, intramuscular injection, external application, drop
The mode of agent and suppository is given, and can be used in preparing postoperative or other wounds and inflammation disease the drug of prevention and treatment, wound
It includes minor operation notch or other wounds that inflammatory type, which is selected from, mucosal ulcer, diabetes, cervical erosion, anal fissure, and anal fistula is soft
Tissue damage, the tumble injury surface of a wound, recurrence sexual trauma, running sore, acne, arthritis, degenerative joint, cystitis, dothienesis, nervous disorder bone
In marrow inflammation, gangrene, leg breach sore, synovitis, gout, nasosinusitis, spondylitis, scapulohumeral periarthritis, pain in waist and lower extremities, periostitis, stomatitis
Any type.
4. surfactant according to claim 3, which is characterized in that selected from glycerine unsaturated fatty acid ester, polyglycereol
Unsaturated fatty acid ester, propylene glycol unsaturated fatty acid ester, sorbitan unsaturated fatty acid ester, polyoxyethylene sorbitol
Acid anhydride unsaturated fatty acid ester, polyoxyethylene unsaturated fatty acid ester, mannitol unsaturated fatty acid ester, pentaerythrite are unsaturated
It is non-in aliphatic ester, sucrose unsaturated fatty acid ester, polyethylene glycol unsaturated alkyl ether and polypropylene glycol unsaturated alkyl ether
One kind in ionic surface active agent, two kinds and two or more.
5. surfactant according to claim 3, which is characterized in that selected from unsaturated fatty acid salt, unsaturated fat
Alcohol sulfuric ester salt, alpha-sulfo unsaturated fatty acid ester, olefin sulphates and the anion surfactant in alkene sulfonate
It is a kind of, two kinds and two or more.
6. surfactant according to claim 3, which is characterized in that be selected from the monosubstituted trimethyl of unsaturated aliphatic hydrocarbyl moiety
Ammonium salt, two substituted dimethyl ammonium salt of unsaturated aliphatic hydrocarbyl moiety, the monosubstituted dimethyl benzyl ammonium salt of unsaturated aliphatic hydrocarbyl moiety, unsaturation
The monosubstituted amine acylate of aliphatic group, unsaturated aliphatic hydrocarbyl moiety two replace amine acylate and N- methyl diethanolamine insatiable hungers
With one kind of the cationic surfactant in aliphatic ester hydrochloride, two kinds and two or more.
7. any one surfactant according to claim 3, which is characterized in that selected from food-grade petroleum ether, poly- second
Glycol unsaturated alkyl ether, one kind of sorbitan monoesters polyoxyethylene ether surface active agent and two kinds.
8. any one according to claims 1 to 7 oil, which is characterized in that selection and ethyl alcohol, propylene glycol, glycerine, oneself
One kind, two kinds and two or more mixing in glycol, butanediol, pentanediol, butantriol, hexanetriol, pass through electrophilic addition ozone
The ozone carburetion containing cosurfactant and surfactant is obtained, glutinous rice or starch material that capacity is 0.1~0.75mL is made
Matter capsulae enterosolubilis is contained with 2~100mL vials, with the dosage of 0.1 ~ 100mL, is administered and is noted using abdominal cavity by oral route
Penetrate, bowel lavage, gavage, intravenous injection, hypodermic injection, intramuscular injection, external application, drops and suppository mode give, can be used in making
It is standby to prevent and treat postoperative or other wounds and inflammation disease drug, wound inflammatory type be selected from include minor operation notch or its
His wound, mucosal ulcer, diabetes, cervical erosion, anal fissure, anal fistula, soft tissue injury, the tumble injury surface of a wound, recurrence sexual trauma, purulence
Sore, acne, arthritis, degenerative joint, cystitis, dothienesis, nervous disorder osteomyelitis, gangrene, leg breach sore, synovitis, pain
Any type in wind, nasosinusitis, spondylitis, scapulohumeral periarthritis, pain in waist and lower extremities, periostitis, stomatitis.
9. ozone carburetion and its any type administration route made of any one according to claims 1 to 8, feature
Be, the ozone carburetion by the approach can with treatment wound, mucosal ulcer, diabetes, cervical erosion, anal fissure,
Anal fistula, soft tissue injury, the tumble injury surface of a wound, recurrence sexual trauma, running sore, acne, arthritis, degenerative joint, cystitis, dothienesis, god
Through lack of proper care osteomyelitis, gangrene, leg breach sore, synovitis, gout, nasosinusitis, spondylitis, scapulohumeral periarthritis, pain in waist and lower extremities, periostitis,
The Drug combination of any type disease in stomatitis can effectively prevent and treat above-mentioned disease.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710215185.1A CN108653320A (en) | 2017-04-02 | 2017-04-02 | The medical usage of ozone carburetion promotion wound, inflammation healing |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710215185.1A CN108653320A (en) | 2017-04-02 | 2017-04-02 | The medical usage of ozone carburetion promotion wound, inflammation healing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108653320A true CN108653320A (en) | 2018-10-16 |
Family
ID=63784542
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710215185.1A Pending CN108653320A (en) | 2017-04-02 | 2017-04-02 | The medical usage of ozone carburetion promotion wound, inflammation healing |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108653320A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110812378A (en) * | 2019-11-25 | 2020-02-21 | 湖南易兴建筑有限公司 | Quaternary ammonium salt ozone oil and preparation method thereof |
| CN110960616A (en) * | 2019-12-30 | 2020-04-07 | 湖北仟枝生物科技有限公司 | Antibacterial repairing ointment for treating bedsore gangrene and preparation method thereof |
| EP3949980A1 (en) | 2020-08-04 | 2022-02-09 | Vassiliki Griva | Compositions for the treatment of atopic dermatitis containing ozonated oils and natural antioxidant agents |
| CN116033824A (en) * | 2021-03-01 | 2023-04-28 | 艾哈迈德·于米特·萨班哲 | Liposome ozone nano solution |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101045031A (en) * | 2007-05-01 | 2007-10-03 | 方华 | Ozone ion instrument for treating haemorrhoids |
| CN106309474A (en) * | 2016-11-01 | 2017-01-11 | 侯建生 | Application of ozonized oil in hyperplasia diseases and infertility |
| CN106389463A (en) * | 2016-11-01 | 2017-02-15 | 侯建生 | Application of ozonized oil in prevention and treatment of autoimmune disease and irritable bowel syndrome |
| CN106466327A (en) * | 2016-11-01 | 2017-03-01 | 侯建生 | Application in dermatosis, obesity and phlebothrombosises preventing and treating for the ozone carburetion |
-
2017
- 2017-04-02 CN CN201710215185.1A patent/CN108653320A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101045031A (en) * | 2007-05-01 | 2007-10-03 | 方华 | Ozone ion instrument for treating haemorrhoids |
| CN106309474A (en) * | 2016-11-01 | 2017-01-11 | 侯建生 | Application of ozonized oil in hyperplasia diseases and infertility |
| CN106389463A (en) * | 2016-11-01 | 2017-02-15 | 侯建生 | Application of ozonized oil in prevention and treatment of autoimmune disease and irritable bowel syndrome |
| CN106466327A (en) * | 2016-11-01 | 2017-03-01 | 侯建生 | Application in dermatosis, obesity and phlebothrombosises preventing and treating for the ozone carburetion |
Non-Patent Citations (4)
| Title |
|---|
| SDSJT发布: "臭氧油的功效", 《网址：HTTP://WWW.360DOC.COM/CONTENT/16/1230/15/21902036_618898956.SHTML》 * |
| ZKHJYX发布: "医用臭氧在临床实践的应用", 《网址：ZKHJYX，HTTPS://WWW.19LOU.COM/BOARD-123456802951210-THREAD-178501362742456211-1.HTML》 * |
| 党东旭，等: "《多功能液针刀微创治疗学》", 31 January 2012, 人民军医出版社 * |
| 活着的道: "生物氧化疗法", 《网址：HTTP://WWW.360DOC.COM/CONTENT/15/1001/23/3902_502761348.SHTML》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110812378A (en) * | 2019-11-25 | 2020-02-21 | 湖南易兴建筑有限公司 | Quaternary ammonium salt ozone oil and preparation method thereof |
| CN110960616A (en) * | 2019-12-30 | 2020-04-07 | 湖北仟枝生物科技有限公司 | Antibacterial repairing ointment for treating bedsore gangrene and preparation method thereof |
| EP3949980A1 (en) | 2020-08-04 | 2022-02-09 | Vassiliki Griva | Compositions for the treatment of atopic dermatitis containing ozonated oils and natural antioxidant agents |
| CN116033824A (en) * | 2021-03-01 | 2023-04-28 | 艾哈迈德·于米特·萨班哲 | Liposome ozone nano solution |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108653320A (en) | The medical usage of ozone carburetion promotion wound, inflammation healing | |
| CN108653319A (en) | Application of the ozone carburetion in gynaecological inflammation disease | |
| CN106309474A (en) | Application of ozonized oil in hyperplasia diseases and infertility | |
| CN106466327A (en) | Application in dermatosis, obesity and phlebothrombosises preventing and treating for the ozone carburetion | |
| CN102743739A (en) | Preparation method for blattodea polypeptide substance, and medical use of blattodea polypeptide substance in anti-herpesvirus | |
| CN102274174A (en) | Oil suspension agent of benzimidazole medicine | |
| CN106619780A (en) | Gynecological antibacterial gel | |
| CN101961347B (en) | Medicinal composition for treating cancer and use thereof | |
| JP2009269904A (en) | Herbal medicinal composition for curing external wound and bedsore and method of manufacturing medicine from the composition | |
| ES2555662T3 (en) | Egg preparation with regenerative, analgesic and / or anti-inflammatory properties | |
| CN103356697B (en) | The oral liquid of a kind of stem cell medicine and preparation thereof | |
| CN102552361A (en) | Externally applied medicinal liquor and preparation method thereof | |
| CN112516229A (en) | Traditional Chinese medicine composition formula for treating internal diseases by external application and preparation process | |
| CN106860474A (en) | A kind of new application of ozone carburetion | |
| CN108685941A (en) | Application of the ozone carburetion in disease of digestive tract and inflammation | |
| CN101507736B (en) | Traditional Chinese medicine preparation for treating senile dementia, ischium lumbar, swollen glands, get-wind or the other rheumatism | |
| CN103800401B (en) | Granulation promoting healing ointment | |
| CN108653318A (en) | Application of the ozone carburetion in eye and ear disease | |
| CN107569453A (en) | It is a kind of that there are the anti-ageing little Huang breasts preparation method and application for repairing jelly scald and eczema containing egg oil | |
| CN102293783B (en) | Traditional Chinese medicinal composition for treating bedsore | |
| CN108685940A (en) | Application of the ozone carburetion in infectious diseases | |
| CN107596355A (en) | A kind of Medical pain easing, the exterior-applied gel subsided a swelling, brought down a fever and preparation method thereof | |
| CN103751277A (en) | Infantile traditional Chinese medicine cooling patch | |
| CN102949712A (en) | Chinese and western composite medicine for treating neoplastic diseases | |
| CN106074625A (en) | A kind of pharmaceutical composition and its production and use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20181016 |